On the Bio front, we are starting to see NMR techniques applied for the analysis of new and
interesting therapeutic targets.
Their involvement has been demonstrated in several diseases, among which chronic inflammation and cancer; therefore, they have been considered
interesting therapeutic targets.
This ability to persist makes them not only
an interesting therapeutic target, but also a potential molecular beacon or biomarker that can facilitate the diagnosis of disease.
Not exact matches
The concept of using the immune system as a
therapeutic is not new, but our ability to use the immune system to
target things we're
interested in is novel.
Szmydynger - Chodobska said the team is also
interested in looking at the proteins as
therapeutic targets.
If a biologist happens to have knowledge related to a
target area that
interests pharmaceutical companies, says French, «That person will be in great demand, but the
therapeutic target du jour varies.»
Our findings suggest that soluble Cd14 could be an
interesting new
therapeutic target for future clinical research.»
There's also a great deal of
interest in using the structures for non-invasive diagnostics and for
targeted therapeutic use.
The Cell Surface Signalling Laboratory is
interested in identifying new
therapeutic targets for both genetic and infectious diseases by using large - scale systematic approaches to discover receptor - ligand interactions that are essential for cellular recognition processes.
This 3D proteomics brain data can be integrated with parallel 3D transcriptomic studies to possibly provide insights to
interesting targets for either
therapeutic intervention or further mechanistic studies.
Dr. Beauchamp's primary area of research
interest has been in colorectal carcinogenesis, the biology of cancer cell invasion and metastasis, and in the identification of novel molecular biomarkers and
therapeutic targets in colorectal and other alimentary tract malignancies.
Although myofibroblasts expressing CXCL12 are associated with the presence of axillary metastases in HER2 breast cancers (BC), the
therapeutic interest of
targeting CXCR4 / CXCL12 axis in the different BC subtypes remains unclear.
Dr. Lanteri is also
interested in using the OMICS approach to identify predictive markers of disease outcome and new
therapeutic targets.
Dr. Jason Yustein's research
interests include furthering the biological, molecular and genetic understanding of pediatric sarcomas, including osteosarcoma and Ewing's sarcoma, through the formation of novel model systems that will lead to the discovery of new
therapeutic targets and subsequent development of new treatment interventions.